1. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry, 1987. 44:660–9.
2. , , , et al. Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms. Biol Psychiatry, 1999. 46:908–20.
3. , , , et al. Linkage analysis of putative schizophrenia gene candidate regions on chromosomes 3p, 5q, 6p, 8p, 20p and 22q in a population-based sampled Finnish family set. Mol Psychiatry, 1998. 3:452–7.
4. , , , et al. A genome-wide search for schizophrenia susceptibility genes. Am J Med Genet, 1998. 81:364–76.
5. , , , et al. Genetic variation in the 22q11 locus and susceptibility to schizophrenia. Proc Natl Acad Sci USA, 2002. 99:16859–64.
6. Hierarchy and heritability: the role of diagnosis and modeling in psychiatric genetics. Am J Psychiatry, 2002. 159:515–18.
7. , , , et al. Late-onset psychosis in the velo-cardio-facial syndrome. Am J Med Genet, 1992. 42:141–2.
8. , , , et al. Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. J Nerv Ment Dis, 1994. 182:476–8.
9. , , , et al. Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder? Am J Psychiatry, 1996. 153:1541–7.
10. , , High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry, 1999. 56:940–5.
11. , , , et al. Neurocognitive profile in 22q11 deletion syndrome and schizophrenia. Schizophr Res, 2006. 87:270–78.
12. , Minimum prevalence of chromosome 22q11 deletions. Am J Hum Genet, 1994. 55:A169.
13. , , , et al. (1996) Prevalence of 22q11 microdeletion. J Med Genet, 1996. 33:719.
14. Velocardiofacial syndrome. Otolaryngol Clin North Am, 2000. 33:1217–40, vi.
15. , 22q11 deletion syndrome: a genetic subtype of schizophrenia. Biol Psychiatry, 1999. 46:882–91.
16. , , , et al. 22q11 deletion syndrome in adults with schizophrenia. Am J Med Genet, 1998. 81:328–37.
17. , , , et al. Clinical features of 78 adults with 22q11 Deletion Syndrome. Am J Med Genet A, 2005. 138:307–13.
18. , (1994) Psychiatric disorders in mental retardation. In Mental Health in Mental Retardation, (Ed.). Cambridge: Cambridge University Press, pp. 79–92.
19. , , , et al. Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc Natl Acad Sci USA, 1995. 92:7612–16.
20. , , , et al. Screening for 22q11 deletions in a schizophrenia population. Schizophr Res, 2001. 52:167–70.
21. , , , et al. 22q11 deletion syndrome in childhood onset schizophrenia: an update. Mol Psychiatry, 2004. 9:225–6.
22. A unitary model of schizophrenia: Bleuler's “fragmented phrene” as schizencephaly. Arch Gen Psychiatry, 1999. 56:781–7.
23. , , , et al. The neurodevelopmental model of schizophrenia: update 2005. Mol Psychiatry, 2005. 10:434–49.
24. , , Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. J Psychiatr Res, 1994. 28:239–65.
25. Development, disease and degeneration in schizophrenia: a unitary pathophysiological model. J Psychiatr Res, 1999. 33:513–21.
26. , , , et al. Familial, obstetric, and other clinical correlates of minor physical anomalies in schizophrenia. Am J Psychiatry, 1991. 148:479–83.
26. , , , et al. Early and late neurodevelopmental disturbances in schizophrenia and their functional consequences. Aust NZ J Psychiatry, 2003. 37:399–406.
27. , , , et al. Minor physical anomalies in schizophrenia. Schizophr Bull, 1989. 15:91–9.
28. , , , et al. Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet, 1994. 344:1398–1402.
29. , , , et al. Patterns of dysmorphic features in schizophrenia. Am J Med Genet, 2001. 105:713–23.
30. , , Neuromotor precursors of schizophrenia. Schizophr Bull, 1994. 20:441–51.
31. Child and adolescent (juvenile onset) schizophrenia. A case control study of premorbid developmental impairments. Br J Psychiatry, 1995. 166:489–95.
32. , The cognitive neuropsychiatric approach to investigating the neurobiology of schizophrenia and other disorders. J Psychosom Res, 2002. 53:655–64.
33. , , , et al. Prevalence and treatment of mental disorders, 1990 to 2003. N Engl J Med, 2005. 352:2515–23.
34. , Global attentional deviance as a marker of risk for schizophrenia: specificity and predictive validity. J Abnorm Psychol, 1985. 94:470–86.
35. , , , et al. Childhood developmental abnormalities in schizophrenia: evidence from high-risk studies. Schizophr Res, 2003. 60:239–58.
36. , , , et al. Imaging frontostriatal function in ultra-high-risk, early, and chronic schizophrenia during executive processing. Arch Gen Psychiatry, 2005. 62:254–62.
37. , , , et al. NIMH-MATRICS survey on assessment of neurocognition in schizophrenia. Schizophr Res, 2004. 72:11–19.
38. , , , et al. Volumes of ventricular system subdivisions measured from magnetic resonance images in first-episode schizophrenic patients. Arch Gen Psychiatry, 1992. 49:531–7.
39. , , , et al. Decreased caudate volume in neuroleptic-naive psychotic patients. Am J Psychiatry, 1998. 155; 774–8.
40. , , , et al. Cerebral gray matter volume deficits in first episode psychosis. Arch Gen Psychiatry, 1998. 55:540–6.
41. , , , et al. Landmark- based morphometric analysis of first-episode schizophrenia. Biol Psychiatry, 1999. 45:1321–8.
42. , , , et al. A review of MRI findings in schizophrenia. Schizophr Res, 2001. 49:1–52.
43. , , , et al. N-acetyl-aspartate levels in the dorsolateral prefrontal cortex in the early years of schizophrenia are inversely related to disease duration. Schizophr Res, 2005. 73:209–19.
44. , , , et al. Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study. Arch Gen Psychiatry, 1998. 55:433–40.
45. , Meta-analysis of thalamic size in schizophrenia. Biol Psychiatry, 2001. 49:28–38.
46. , , , et al. Decreased caudal anterior cingulate gyrus volume and positive symptoms in schizophrenia. Psychiatry Res, 2005. 139:239–47.
47. , , , et al. Premorbid indicators and risk for schizophrenia: a selective review and update. Schizophr Res, 2005. 79:45–57.
48. , , , et al. Quantitative magnetic resonance imaging of human brain development: ages 4–18. Cereb Cortex, 1996. 6:551–60.
49. , , , et al. Imaging normal and abnormal brain development: new perspectives for child psychiatry. Aust N Z J Psychiatry, 2001. 35:272–81.
50. , , Changes in synaptic density in motor cortex of rhesus monkey during fetal and postnatal life. Brain Res Dev Brain Res, 1989. 50:11–32.
51. , S. Regional differences in synaptogenesis in human cerebral cortex. J Comp Neurol, 1997. 387:167–78.
52. , , , et al. (2006) Puberty-related influences on brain development. Mol Cell Endocrinol, 2006. 254–5:154–62.
53. , , , et al. Longitudinal mapping of cortical thickness and brain growth in normal children. J Neurosci, 2004. 24:8223–31.
54. , , , et al. Mapping adolescent brain change reveals dynamic wave of accelerated grey matter loss in very early-onset schizophrenia. Proc Natl Acad Sci USA, 2001. 98:11650–5.
55. , Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch Gen Psychiatry, 2000. 57:637–48.
56. , , , et al. A combined analysis of D22S278 marker alleles in affected sib-pairs: support for a susceptibility locus for schizophrenia at chromosome 22q12. Schizophrenia Collaborative Linkage Group (Chromosome 22). Am J Med Genet, 1996. 67:40–5.
57. , , , et al. The velo-cardio-facial syndrome: a clinical and genetic analysis. Pediatrics, 1981. 67:167–72.
58. , , , et al. Intelligence and psychosocial adjustment in velocardiofacial syndrome: a study of 37 children and adolescents with VCFS. J Med Genet, 1997. 34:453–8.
59. , , , et al. Psychoeducational profile of the 22q11.2 microdeletion: a complex pattern. J Pediatr, 1999. 134:193–8.
60. , , , et al. Neuropsychological profile of children and adolescents with the 22q11.2 microdeletion. Genet Med, 2001. 3:34–9.
61. , , , et al. Language skills in children with velocardiofacial syndrome (deletion 22q11.2). J Pediatr, 2002. 140:753–8.
62. , , Wang P. P., et al. Cognitive and behavior profile of preschool children with chromosome 22q11.2 deletion. Am J Med Genet, 1999 85:127–33.
63. , , , et al. Neuropsychological characteristics of children with the 22q11 Deletion Syndrome: a descriptive analysis. Child Neuropsychol, 2005a. 11:39–53.
64. , (1999) Turner syndrome: a cognitive neuroscience approach. In Neurodevelopmental Disorders, (Ed.). Cambridge, Mass.: The MIT Press, pp. 223–50.
65. , , Associations between prepulse inhibition and executive visual attention in children with the 22q11 deletion syndrome. Mol Psychiatry, 2005b. 10:553–62.
66. , , , et al. COMT Val108/158 Met modifies mismatch negativity and cognitive function in 22q11 deletion syndrome. Biol Psychiatry, 2005. 58:23–31.
67. , , , et al. Maladaptive conflict monitoring as evidence for executive dysfunction in children with chromosome 22q11.2 deletion syndrome. Dev Sci, 2005. 8:36–43.
68. , , , et al. Visuospatial and numerical cognitive deficits in children with chromosome 22q11.2 deletion syndrome. Cortex, 2005a. 41:145–55.
69. , , , et al. Schizophrenic-like neurocognitive deficits in children and adolescents with 22q11 deletion syndrome. Am J Med Genet, B Neuropsychiatr Genet, 2007. 144:27–36.
70. , , , et al. Morphometric assessment of the heteromodal association cortex in schizophrenia. Am J Psychiatry, 2004. 161:322–31.
71. , , , et al. The behavioural phenotype in velo-cardio-facial syndrome (VCFS): from infancy to adolescence. Genet Couns, 1999. 10:79–88.
72. , , , et al. Chromosome 22q11 deletion syndrome: update and review of the clinical features, cognitive-behavioral spectrum, and psychiatric complications. Am J Med Genet, 2000. 97:128–35.
73. , , , et al. Velo-cardio-facial syndrome: implications of microdeletion 22q11 for schizophrenia and mood disorders. Am J Med Genet, 2001. 105:354–62.
74. , , , et al. Obsessive-compulsive disorder in patients with velocardiofacial (22q11 deletion) syndrome. Am J Med Genet, B Neuropsychiatr Genet, 2004. 126:99–105.
75. , , , et al. Behavior problems and personality aspects of 40 children with velo-cardio-facial syndrome. Genet Couns, 1999. 10:89–93.
76. , , , et al. Psychiatric disorders and behavioral problems in children with velocardiofacial syndrome: usefulness as phenotypic indicators of schizophrenia risk. Biol Psychiatry, 2002. 51:312–18.
77. , Velo-cardio-facial syndrome: a model for understanding the genetics and pathogenesis of schizophrenia. Br J Psychiatry, 2001. 179:397–402.
78. Annotation: velo-cardio-facial syndrome. J Child Psychol Psychiatry, 2005. 46:563–71.
79. , , , et al. (2006a) Psychotic symptoms in children and adolescents with 22q11.2 deletion syndrome: Neuropsychological and behavioral implications. Schizophr Res, 2006a. 84:187–93.
80. , Adolescents and young adults with 22q11 deletion syndrome: psychopathology in an at-risk group. Br J Psychiatry, 2005. 186:115–20.
81. , , , et al. Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Arch Gen Psychiatry, 2002. 59:449–56.
82. , , , et al. Neuropsychological deficits in children associated with increased familial risk for schizophrenia. Schizophr Res, 2004. 67:123–30.
83. , , Brain anomalies in velo-cardio-facial syndrome. Am J Med Genet, 1994. 54:100–6.
84. , , , et al. Enlarged Sylvian fissures in infants with interstitial deletion of chromosome 22q11. Am J Med Genet, 1997. 74:538–43.
85. , Midline brain anomalies and schizophrenia in people with CATCH 22 syndrome. Br J Psychiatry, 1998. 172:518–20.
86. , , , et al. Qualitative MRI findings in adults with 22q11 deletion syndrome and schizophrenia. Biol Psychiatry, 1999. 46:1436–42.
87. , , , et al. Abnormalities of the corpus callosum in nonpsychotic children with chromosome 22q11 deletion syndrome. Neuroimage, 2004. 21:1399–406.
88. , , , et al. Structural brain abnormalities associated with deletion at chromosome 22q11: quantitative neuroimaging study of adults with velo-cardio-facial syndrome. Br J Psychiatry, 2001. 178:412–19.
89. , , , et al. Velocardiofacial syndrome in childhood-onset schizophrenia. J Am Acad Child Adolesc Psychiatry, 1999. 38:1536–43.
90. , , , et al. Children and adolescents with velocardiofacial syndrome: a volumetric MRI study. Am J Psychiatry, 2000. 157:409–15.
91. , Posterior cortical white matter anomalies in velocardiofacial syndrome. pp 1S-173S Biol Psychiatry, 2000. 47(Suppl 1): S102–73S.
92. , , , et al. Velocardiofacial syndrome: are structural changes in the temporal and mesial temporal regions related to schizophrenia? Am J Psychiatry, 2001. 158:447–53.
93. , , , et al. Volumetric, connective, and morphologic changes in the brains of children with chromosome 22q11.2 deletion syndrome: an integrative study. Neuroimage, 2005b. 25:169–80.
94. , , , et al. Mapping cortical thickness in children with 22q11.2 deletions. Cereb Cortex, 2007. 17:1889–98. [Epub Oct 20, 2006.]
95. , , , et al. Hippocampal volume reduction in 22q11.2 deletion syndrome. Neuropsychologia, 2006b. 44:2360–5.
96. , , , et al. Morphometry of the head of the caudate nucleus in patients with velocardiofacial syndrome (del 22q11.2). Acta Paediatr, 2000. 89:546–9.
97. , , , et al. Increased basal ganglia volumes in velo-cardio-facial syndrome (deletion 22q11.2). Biol Psychiatry, 2002. 52:68–70.
98. , , , et al. Frontal and caudate alterations in velocardiofacial syndrome (deletion at chromosome 22q11.2). J Child Neurol, 2004. 19:337–42.
99. , , , et al. Brain and behaviour in children with 22q11.2 deletion syndrome: a volumetric and voxel-based morphometry MRI study. Brain, 2006. 129:1218–28.
100. , , , et al. Temporal lobe anatomy and psychiatric symptoms in velocardiofacial syndrome (22q11.2 deletion syndrome). J Am Acad Child Adolesc Psychiatry, 2006. 45:587–95.
101. , , , et al. Behavior and corpus callosum morphology relationships in velocardiofacial syndrome (22q11.2 deletion syndrome). Psychiatry Res, 2005. 138:235–45.
102. , , , et al. Decreased left amygdala and hippocampal volumes in young offspring at risk for schizophrenia Schizophr Res, 2002a. 58:173–83.
103. , , , et al. Abnormalities of the corpus callosum in first episode, treatment naive schizophrenia. J Neurol Neurosurg Psychiatry, 2002b. 72:757–60.
104. , , , et al. Regional brain abnormalities in 22q11.2 deletion syndrome: association with cognitive abilities and behavioral symptoms. Neurocase, 2004b. 10:198–206.
105. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res, 1982. 17:319–34.
106. , , , et al. Clinical characteristics of schizophrenia associated with velo-cardio-facial syndrome. Schizophr Res, 1999. 35:105–12.
107. , , , et al. The schizophrenia phenotype in 22q11 deletion syndrome. Am J Psychiatry, 2003. 160:1580–6.
108. Toward an integrated theory of schizotaxia, schizotypy and schizophrenia. J Personality Disorders, 1990. 4:1–99.
109. , , , et al. Cognitive deficits associated with schizophrenia in velo-cardio-facial syndrome. Schizophr Res, 2004b. 70:223–32.
110. , , , et al. Investigation of white matter structure in velocardiofacial syndrome: a diffusion tensor imaging study. Am J Psychiatry, 2003. 160:1863–9.
111. , , , et al. Structural brain abnormalities in patients with schizophrenia and 22q11 deletion syndrome. Biol Psychiatry, 2002. 51:208–15.
112. , , , et al. Brain anatomy in adults with velocardiofacial syndrome with and without schizophrenia: preliminary results of a structural magnetic resonance imaging study. Arch Gen Psychiatry, 2004a. 61:1085–96.
113. , , , et al. Methylphenidate treatment for attention-deficit/hyperactivity disorder in children and adolescents with velocardiofacial syndrome: an open-label study. J Clin Psychiatry, 2003. 64:1163–9.
114. , , , et al. (1995) Follow-up report of potential linkage for schizophrenia on chromosome 22q: Part 3. Am J Med Genet, 1995. 60:172–3.
115. , , , et al. Linkage studies suggest a possible locus for bipolar disorder near the velo-cardio-facial syndrome region on chromosome 22. Am J Med Genet, 1997. 74:121–8.
116. , , , et al. A genome survey indicates a possible susceptibility locus for bipolar disorder on chromosome 22. Proc Natl Acad Sci USA, 2001. 98:585–90.
117. , , , et al. Characterization and mutation analysis of goosecoid-like (GSCL), a homeodomain-containing gene that maps to the critical region for VCFS/DGS on 22q11. Genomics, 1997. 46:364–72.
118. , , , et al. (1997) Identification of a new human catenin gene family member (ARVCF) from the region deleted in velo-cardio-facial syndrome. Genomics, 1997. 41:75–83.
119. , , , et al. Deletion mapping of 22q11 in CATCH22 syndrome: identification of a second critical region. Am J Hum Genet, 1996. 58:1377–81.
120. , , , et al. Another critical region for deletion of 22q11: a study of 100 patients. Am J Med Genet, 1997. 72:180–5.
121. , The molecular genetics of the 22q11-associated schizophrenia. Brain Res Mol Brain Res, 2004. 132:95–104.
122. , Neurofibromatosis type 1: a model condition for the study of the molecular basis of variable expressivity in human disorders. Am J Med Genet, 1999. 89:7–13.
123. Phenotypic variability: genetics and chance–deletion 22q11 and schizophrenia. Ned Tijdschr Geneeskd, 2002. 146:2016–19.
124. , , , et al. Evidence for association between novel polymorphisms in the PRODH gene and schizophrenia in a Chinese population. Am J Med Genet, B Neuropsychiatr Genet, 2004. 129:13–15.
125. , , , et al. Evidence that the gene encoding ZDHHC8 contributes to the risk of schizophrenia. Nat Genet, 2004. 36:725–31.
126. , , , et al. Functional consequences of PRODH missense mutations. Am J Hum Genet, 2005. 76:409–20.
127. , , 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model. J Neurochem, 1994. 63:972–9.
128. , , , et al. Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry, 2001. 50:825–44.
129. , , Catechol O-methyltransferase pharmacogenetics: photoaffinity labelling and western blot analysis of human liver samples. Pharmacogenetics, 1993. 3:116–22.
130. , , , et al. Catechol-O-methyl-transferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci USA, 1998. 95:9991–6.
131. , , , et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA, 2001. 98:6917–22.
132. , , , et al. Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biol Psychiatry, 2002. 52:701–7.
133. , , , et al. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry, 2002. 159:652–4.
134. , , , et al. Preferential transmission of the high activity allele of COMT in schizophrenia. Psychiatr Genet, 1996. 6:131–3.
135. , , , et al. Higher scores of self reported schizotypy in healthy young males carrying the COMT high activity allele. Mol Psychiatry, 2002. 7:706–11.
136. , , , et al. Association between Val108/158 Met polymorphism of the COMT gene and schizophrenia. Am J Med Genet B Neuropsychiatr Genet, 2003. 120:47–50.
137. , , , et al. (2005) Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: a meta-analysis of case-control studies. Mol Psychiatry, 2005. 10:765–70.
138. , , , et al. Effects of a functional COMT polymorphism on prefrontal cognitive function in patients with 22q11.2 deletion syndrome. Am J Psychiatry, 2004a. 161:1700–2.
139. , , , et al. Cognitive correlates of a functional COMT polymorphism in children with 22q11.2 deletion syndrome. Clin Genet, 2006. 69:234–8.
140. , , , et al. Association of the low-activity COMT 158Met allele with ADHD and OCD in subjects with velocardiofacial syndrome. Int J Neuropsychopharmacol, 2007. 10:301–8. [Epub May 31, 2006.]
141. , , , et al. COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11. 2 deletion syndrome. Nat Neurosci, 2005. 8:1500–2.
142. , , , et al. Catechol-O-methyl transferase and expression of schizophrenia in 73 adults with 22q11 deletion syndrome. Biol Psychiatry, 2007. 61:1135–40. [Epub Jan 9, 2007.]
143. , , D(1) receptors in prefrontal cells and circuits. Brain Res Brain Res Rev, 2000. 31:295–301.
144. , , , et al. Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry, 1991. 148:1474–86.
145. (1991) Prefrontal cortical dysfunction in schizophrenia: the relevance of working memory. In Psychopathology and the Brain, and (Eds.). New York: Raven Press, pp. 1–23.
146. , , Cognition and control in schizophrenia: a computational model of dopamine and prefrontal function. Biol Psychiatry, 1999. 46:312–28.
147. , , , et al. Variants in the catechol-o-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families. Mol Psychiatry, 2004b. 9:962–7.
148. , , , et al. COMT haplotypes suggest P2 promoter region relevance for schizophrenia. Mol Psychiatry, 2004. 9:859–70.
149. , , , et al. Separate and interacting effects within the catechol-O-methyltransferase (COMT) are associated with schizophrenia. Mol Psychiatry, 2005. 10:589–97.
150. , , Molecular cloning and expression of a high affinity L-proline transporter expressed in putative glutamatergic pathways of rat brain. Neuron, 1992. 8:915–26.
151. , , , et al. The mammalian brain high-affinity L-proline transporter is enriched preferentially in synaptic vesicles in a subpopulation of excitatory nerve terminals in rat forebrain. J Neurosci, 1999. 19:21–33.
152. , The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry, 2001. 158:1367–77.
153. , , , et al. Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat Med, 2006. 12:824–8.
154. , , , et al. Transcriptional and behavioral interaction between 22q11. 2 orthologs modulates schizophrenia-related phenotypes in mice. Nat Neurosci, 2005. 8:1586–94.
155. , Differential gene expression in p53-mediated apoptosis-resistant vs. apoptosis-sensitive tumor cell lines. Proc Natl Acad Sci USA, 2000. 97:13009–14.
156. , , , et al. Detailed analysis of PRODH and PsPRODH reveals no association with schizophrenia. Am J Med Genet B Neuropsychiatr Genet, 2003b. 120:42–6.
157. , , , et al. (2006) Hyperprolinemia is not associated with childhood onset schizophrenia. Am J Med Genet B Neuropsychiatr Genet, 2006. 141:192.
158. , , , et al. Association between PRODH and schizophrenia is not confirmed. Mol Psychiatry, 2003a. 8:644–5.
159. , , , et al. (2006) Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome. Hum Mol Genet, 2007. 16:83–91. [Epub Nov 29, 2006.]
160. , , , et al. Dual palmitoylation of PSD-95 mediates its vesiculotubular sorting, postsynaptic targeting, and ion channel clustering. J Cell Biol, 2000. 148:159–72.
161. , , , et al. Case-control study and transmission disequilibrium test provide consistent evidence for association between schizophrenia and genetic variation in the 22q11 gene ZDHHC8. Hum Mol Genet, 2004a. 13:2991–5.
162. , , , et al. Association study of a promoter polymorphism of UFD1L gene with schizophrenia. Am J Med Genet, 2001. 105:529–33.
163. , Reply: role of the dHAND-UFD1L pathway. Trends Genet, 1999. 15:253–4.
164. , , , et al. Role of TBX1 in human del22q11.2 syndrome. Lancet, 2003. 362:1366–73.
165. , , , et al. Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome. Proc Natl Acad Sci USA, 2006. 103:7729–34.
166. , , , et al. (2003) A comprehensive analysis of 22q11 gene expression in the developing and adult brain. Proc Natl Acad Sci USA, 2003. 100:14433–8.
167. , , Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl), 2001. 156:234–58.
168. , , , et al. Congenital heart disease in mice deficient for the DiGeorge syndrome region. Nature, 1999. 401:379–83.
169. , , , et al. Behavior of mice with mutations in the conserved region deleted in velocardiofacial/DiGeorge syndrome. Neurogenetics, 2006. 7:247–57.
170. , , , et al. Mice deleted for the DiGeorge/velocardiofacial syndrome region show abnormal sensorimotor gating and learning and memory impairments. Hum Mol Genet, 2001. 10:2645–50.
171. , , , et al. The gene encoding proline dehydrogenase modulates sensorimotor gating in mice. Nat Genet, 1999. 21:434–9.
172. , , , et al. A 200-kb region of human chromosome 22q11.2 confers antipsychotic-responsive behavioral abnormalities in mice. Proc Natl Acad Sci USA, 2005. 102:19132–7.
173. , , , et al. Altered expression of hippocampal dentate granule neuron genes in a mouse model of human 22q11 deletion syndrome. Schizophr Res, 2006. 88:251–9.
174. , , , et al. Deficient hippocampal Neuron, expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. Biol Psychiatry, 2005. 58:85–96.